X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth. (Q54724262)

3 June 2018

title

X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth. (English)

1 reference

3 June 2018

1 reference

Yuan-Jia Chen

1

1 reference

3 June 2018

Alexander Vortmeyer

2

1 reference

3 June 2018

Zhengping Zhuang

3

1 reference

3 June 2018

Fathia Gibril

4

1 reference

3 June 2018

Robert T Jensen

5

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

3 June 2018

published in

Cancer

1 reference

3 June 2018

volume

100

1 reference

3 June 2018

issue

7

1 reference

3 June 2018

page(s)

1379-1387

1 reference

3 June 2018

Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Loss of heterozygosity on chromosome XP22.2-p22.13 and Xq26.1-q27.1 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

DNA copy number losses in human neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Sex chromosome anomalies in pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Identification of genetic markers for prostatic cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Sex chromosome abnormalities in lung cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Pathological and karyotypic abnormalities in advanced gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor supressor gene for renal oncocytomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Chromosomal alterations in human pancreatic endocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Genomic imbalances in the progression of endocrine pancreatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Surgery to cure the Zollinger-Ellison syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Zollinger-Ellison syndrome. Clinical presentation in 261 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20104

7 January 2021

Identifiers

DOI

10.1002/CNCR.20104

1 reference

3 June 2018

PubMed ID

15042671

1 reference

3 June 2018